540
Views
3
CrossRef citations to date
0
Altmetric
RESEARCH Original Articles

Patient adherence to prescribed medication instructions for dyspepsia: The DIAMOND-study

, , , , , , , , , & show all
Pages 79-85 | Received 25 Mar 2011, Accepted 02 Dec 2011, Published online: 16 May 2012
 

Abstract

Background: Insight into patient adherence is needed to enable an effect evaluation of medication for dyspepsia.

Objectives: Adherence was explored by investigating two adherence outcome measures (completeness and intake fidelity) using data from the DIAMOND-study.

Methods: The DIAMOND-study is a pragmatic RCT comparing a ‘step-up’ with a ‘step-down’ treatment strategy. In step 1 participants (n =653) were instructed to use five pills/day for maximally 30 days: an antacid 4dd plus a placebo 1dd (‘step-up’) or a proton pump inhibitor 1dd plus a placebo 4dd (‘step-down’). If the complaints persisted, step 2 was started (H2-receptor antagonist 2dd), and subsequently step 3 (five pills/day, placebo and verum vice versa from step 1). Completeness was assessed by pill counts, intake fidelity by patient questionnaires measuring the degree to which patients adhered to specific instructions concerning timing, frequency, dose and way of intake.

Results: In step 1, patients used on average 3.9 pills/day (78% of the prescribed doses), in step 2, 1.7 pills/day (85%) and in step 3, 3.6 pills/day (72%). For the four times daily pills, half of the patients used less than 80% of the prescribed pills per day. This was one third of the patients for the twice daily pills and one quarter for the once daily pills. There were no completeness differences between active or placebo medication and no differences between the study arms. As regards intake fidelity, 70% of the patients made one or more errors in the medication intake.

Conclusion: There is room for improvement in adherence rates for dyspepsia medication.

Acknowledgements

The authors wish to thank all general practitioners and patients for participating in the DIAMOND trial.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.